Microba Life Sciences logo
MAPMicroba Life Sciences
Trade MAP now
Microba Life Sciences primary media

About Microba Life Sciences

Microba Life Sciences (ASX:MAP) is a precision microbiome science company transforming human health through the development of novel microbiome-derived therapeutics and new diagnostic tools. Leveraging its proprietary analysis and discovery platforms, Microba identifies key relationships between gut microorganisms and health, paving the way for innovative medical treatments.

What is MAP known for?

Snapshot

Public AU
Ownership
2017
Year founded
81
Employees
Queensland, Australia
Head office
1 of 169
AU Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
Australia

Produtos e/ou serviços de Microba Life Sciences

  • Microba Personal Testing: This service provides personalized gut microbiome analysis to individuals, helping them understand the unique composition of their gut microbiome and its potential impact on their health.
  • Microba Research Testing: This service offers comprehensive gut microbiome analysis for researchers, enabling them to conduct studies on the microbiome's role in various health conditions.
  • Microbiota-based Therapeutics: The company is developing novel therapeutics derived from the gut microbiome, with a focus on treating inflammatory bowel disease (IBD).
  • PancAlert: In collaboration with Mainz Biomed, Microba is developing PancAlert, a diagnostic tool for early detection of pancreatic cancer.
  • Next-Generation Healthcare Testing: Microba is developing next-generation healthcare testing solutions that leverage the power of the gut microbiome to provide personalised insights and improve patient outcomes.
  • Microbiome-based Diagnostic Tools: The company is exploring the development of microbiome-based diagnostic tools for various diseases, aiming to improve diagnostic accuracy and timeliness.

equipe executiva do Microba Life Sciences

  • Dr. Luke ReidChief Executive Officer
  • Prof. Gene TysonCo-Founder & Non-Executive Director
  • Mr. James HeathCFO & Company Secretary
  • Prof. Philip HugenholtzCo-Founder & Chair of Scientific Advisory Board
  • Dr. David WoodChief Technology Officer
  • Prof. Lutz KrauseChief Scientific Officer
  • Dr. Nicola AngelHead of Laboratory Operations & Laboratory Director
  • Keith ByrneHead of Test Operations
  • Eric DaviesChief Revenue Officer
  • Alaster Stockwell-JonesManaging Director of UK

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.